Abstract
Elucidating the functions of a particular gene is paramount to the understanding of how its dysfunction contributes to disease. This is especially important when the gene is implicated in multiple different disorders. One such gene is methyl-CpG-binding protein 2 (MECP2), which has been most prominently associated with the neurodevelopmental disorder Rett syndrome, as well as major neuropsychiatric disorders such as autism and schizophrenia. Being initially identified as a transcriptional regulator that modulates gene expression and subsequently also shown to be involved in other molecular events, dysfunction of the MeCP2 protein has the potential to affect many cellular processes. In this chapter, we will briefly review the functions of the MeCP2 protein and how its mutations are implicated in Rett syndrome and other neuropsychiatric disorders. We will further discuss about the mouse models that have been generated to specifically dissect the function of MeCP2 in different cell types and brain regions. It is envisioned that such thorough and targeted examination of MeCP2 functions can aid in enlightening the role that it plays in normal and dysfunctional physiological systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gilman SR, Chang J, Xu B, Bawa TS, Gogos JA, Karayiorgou M, Vitkup D (2012) Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci 15(12):1723–1728
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) Identification of risk loci with shared effects on five major psychiatric disorders - a genome-wide analysis. Lancet 381(9875):1371–1379
Heinzen EL, Neale BM, Traynelis SF, Allen AS, Goldstein DB (2015) The genetics of neuropsychiatric diseases: looking in and beyond the exome. Annu Rev Neurosci 38:47–68
Pollimanti R, Gelernter J (2017) Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder. PLoS Genet 13(2):e1006618
Sullivan PF, Daly MJ, O’Donovan M (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13(8):537–551
Lotan A, Fenckova M, Bralten J, Alttoa A, Dixson L, Williams RW, van der Voet M (2014) Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders. Front Neurosci 8:331
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45(9):984–994
Zhao H, Nyholt DR (2017) Gene-based analyses reveal novel genetic overlap and allelic heterogeneity across five major psychiatric disorders. Hum Genet 136(2):263–274
Faraone SV, Biederman J, Wozniak J (2012) Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: a meta-analysis of family genetic studies. Am J Psychiatry 169:1256–1266
Hamilton JP, Chen MC, Waugh CE, Joormann J, Gotlib IH (2014) Distinctive and common neural underpinnings of major depression, social anxiety, and their comorbidity. Soc Cogn Affect Neurosci 10(4):552–560
Joshi G, Faraone SV, Wozniak J, Tarko L, Fried R, Galdo M, Furtak SL, Biederman J (2014) Symptom profile of ADHD in youth with high-functioning autism spectrum disorder: a comparative study in psychiatrically referred populations. J Atten Disord 21(10):846–855
Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156(2-3):234–358
Spiegelhalder K, Regen W, Nanovska S, Baglioni C, Riemann D (2013) Comorbid sleep disorders in neuropsychiatric disorders across the life cycle. Curr Psychiatry Rep 15(6):364
Foussias G, Agid O, Fervaha G, Remington G (2014) Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. Eur Neuropsychopharmacol 24(5):693–709
Zhu X, Need AC, Petrovski S, Goldstein DB (2014) One gene, many neuropsychiatric disorders: lessons from Mendelian diseases. Nat Neurosci 17(6):773–781
Adkins NL, Georgel PT (2011) MeCP2: structure and function. Biochem Cell Biol 89(1):1–11
Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY (2002) Insight into Rett syndrome: MeCP2 levels display tissue and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11:115–124
Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ, Jones JR, Scherer SW, Schanen NC, Friez MJ, Vincent JB, Minassian BA (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36(4):339–341
Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34(36):11929–11947
Nan X, Campoy FJ, Bird A (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88(4):471–481
Wakefield RI, Smith BO, Nan X, Free A, Soteriou A, Uhrin D, Bird AP, Barlow PN (1999) The solution structure of the domain from MeCP2 that binds to methylated DNA. J Mol Biol 291(5):1055–1065
Nan X, Bird A (2001) The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome. Brain Dev Suppl 1:S32–S37
Meehan RR, Lewis JD, Bird AP (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20(19):5085–5092
Ballestar E, Yusufzai TM, Wolffe AP (2000) Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 39(24):7100–7106
Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N (2012) MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151(7):1417–1430
Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69(6):905–914
Hansen JC, Ghosh RP, Woodcock CL (2010) Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life 62(10):732–738
Zhao N, Ma D, Leong WY, Han J, VanDongen A, Chen T, Goh EL (2015) The methyl-CpG-binding domain (MBD) is crucial for MeCP2’s dysfunction-induced defects in adult newborn neurons. Front Cell Neurosci 9:158
Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393(6683):386–389
Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278(6):4035–4040
Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, Hansen JC (2003) Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 278(34):32181–32188
Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A 104(49):19416–19421
Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320(5880):1224–1229
Zlatanova J (2005) MeCP2: the chromatin connection and beyond. Biochem Cell Biol 83(3):251–262
Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19(2):187–191
Klose RJ, Bird AP (2004) MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J Biol Chem 279(45):46490–46496
Buschdorf JP, Strätling WH (2004) A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J Mol Med 82(2):135–143
Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, Zoghbi HY (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A 102(49):17551–17558
Gabel HW, Kinde B, Stroud H, Gilbert CS, Harmin DA, Kastan NR, Hemberg M, Ebert DH, Greenberg ME (2015) Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 522(7554):89–93
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185–188
Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670–679
Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL, Lo IF, Zoghbi HY, Schanen NC, Francke U (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65:1520–1529
Bienvenu T, Carrie A, de Roux N, Vinet MC, Jonveaux P, Couvert P, Villard L, Arzimanoglou A, Beldjord C, Fontes M, Tardieu M, Chelly J (2000) MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 9:1377–1384
Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F (2000) Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 9:1369–1375
Lee SS, Wan M, Francke U (2001) Spectrum of MECP2 mutations in Rett syndrome. Brain Dev 23(Suppl 1):S138–S143
Trappe R, Laccone F, Cobilanschi J, Meins M, Huppke P, Hanefeld F, Engel W (2001) MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 68(5):1093–1101
Hagberg B, Aicardi J, Dias K, Ramos O (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol 14:471–479
Hagberg B, Goutieres F, Hanefeld F, Rett A, Wilson J (1985) Rett syndrome: criteria for inclusion and exclusion. Brain Dev 7:372–373
Kerr AM, Stephenson JB (1985) Rett’s syndrome in the west of Scotland. Br Med J (Clin Res Ed) 291:579–582
Villard L, Kpebe A, Cardoso C, Chelly PJ, Tardieu PM, Fontes M (2000) Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 55(8):1188–1193
Zeev BB, Yaron Y, Schanen NC, Wolf H, Brandt N, Ginot N, Shomrat R, Orr-Urtreger A (2002) Rett syndrome: clinical manifestations in males with MECP2 mutations. J Child Neurol 17(1):20–24
Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56:422–437
Nomura Y (2005) Early behaviour characteristics and sleep disturbance in Rett syndrome. Brain Dev 27(Suppl 1):S35–S42
Hagberg B (2002) Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 8(2):61–65
Hagberg B (2005) Rett syndrome: long-term clinical follow-up experiences over four decades. J Child Neurol 20:722–727
Roze E, Cochen V, Sangla S, Bienvenu T, Roubergue A, Leu-Semenescu S, Vidaihet M (2007) Rett syndrome: an overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, Parkinsonism, and dystonia? Mov Disord 22:387–389
Armstrong DD (2005) Neuropathology of Rett syndrome. J Child Neurol 20:747–753
Casanova MF, Buxhoeveden D, Switala A, Roy E (2003) Rett syndrome as a minicolumnopathy. Clin Neuropathol 22:163–168
Bauman ML, Kemper TL, Arin DM (1995) Pervasive neuroanatomic abnormalities of the brain in three cases of Rett’s syndrome. Neurology 45:1581–1586
Zappella M, Meloni I, Longo I, Hayek G, Renieri A (2001) Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet 104:14–22
Amir RE, Fang P, Yu Z, Glaze DG, Percy AK, Zoghbi HY, Roa BB, Van den Veyver IB (2005) Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. J Med Genet 42:e15
Quenard A, Yilmaz S, Fontaine H, Bienvenu T, Moncla A, des Portes V, Rivier F, Mathieu M, Raux G, Jonveaux P, Riviere F, Mathieuf M, Rauxg G, Jonveauxa P, Philippe C (2006) Deleterious mutations in exon 1 of MECP2 in Rett syndrome. Eur J Med Genet 49:313–322
Saunders CJ, Minassian BE, Chow EW, Zhao W, Vincent JB (2009) Novel exon 1 mutations in MECP2 implicate isoform MeCP2_e1 in classical Rett syndrome. Am J Med Genet A 149A:1019–1023
Smeets E, Terhal P, Casaer P, Peters A, Midro A, Schollen E, van Roozendaal K, Moog U, Matthijs G, Herbergs J, Smeets H, Curfs L, Schrander-Stumpel C, Fryns JP (2005) Rett syndrome in females with CTS hot spot deletions: a disorder profile. Am J Med Genet A 132A(2):117–120
de Leon-Guerrero SD, Pedraza-Alva G, Perez-Martinez L (2011) In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system. Eur J Neurosci 33:1563–1574
Tudor M, Akbarian S, Chen RZ, Jaenisch R (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 99(24):15536–15541
Jordan C, Li HH, Kwan HC, Francke U (2007) Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet 8:36
Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi HY (2009) Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 18(13):2431–2442
Zhao YT, Goffin D, Johnson BS, Zhou Z (2013) Loss of MeCP2 function is associated with distinct gene expression changes in the striatum. Neurobiol Dis 59:257–266
Johnson BS, Zhao YT, Fasolino M, Lamonica JM, Kim YJ, Georgakilas G, Wood KH, Bu D, Cui Y, Goffin D, Vahedi G, Kim TH, Zhou Z (2017) Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome. Nat Med 23(10):1203–1214
Hoffbuhr KC, Moses LM, Jerdonek MA, Naidu S, Hoffman EP (2002) Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev 8(2):99–105
Dragich J, Houwink-Manville I, Schanen C (2000) Rett syndrome: a surprising result of mutation in MECP2. Hum Mol Genet 9(16):2365–2375
Huppke P, Held M, Laccone F, Hanefeld F (2003) The spectrum of phenotypes in females with Rett Syndrome. Brain Dev 25(5):346–351
Young JI, Zoghbi HY (2004) X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am J Hum Genet 74(3):511–520
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. APA, Washington, DC
Gandal MJ, Edgar JC, Ehrlichman RS, Mehta M, Roberts TP, Siegel SJ (2010) Validating γ oscillations and delayed auditory responses as translational biomarkers of autism. Biol Psychiatry 68(12):1100–1106
Roberts TP, Khan SY, Rey M, Monroe JF, Cannon K, Blaskey L, Woldoff S, Qasmieh S, Gandal M, Schmidt GL, Zarnow DM, Levy SE, Edgar JC (2010) MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism. Autism Res 3(1):8–18
Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11(2):100–113
Gandal MJ, Edgar JC, Klook K, Siegel SJ (2012) Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology 62(3):1504–1518
Wulffaert J, Van Berckelaer-Onnes IA, Scholte EM (2009) Autistic disorder symptoms in Rett syndrome. Autism 13(6):567–581
Neul JL (2012) The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues Clin Neurosci 14(3):253–262
Lam CW, Yeung WL, Ko CH, Poon PM, Tong SF, Chan KY, Lo IF, Chan LY, Hui J, Wong V, Pang CP, Lo YM, Fok TF (2000) Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet 37(12):E41
Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML, Vance JM, Pericak-Vance MA (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 28(3):205–211
Li H, Yamagata T, Mori M, Yasuhara A, Momoi MY (2005) Mutation analysis of methyl-CpG binding protein family genes in autistic patients. Brain Dev 27(5):321–325
Campos M Jr, Pestana CP, dos Santos AV, Ponchel F, Churchman S, Abdalla-Carvalho CB, dos Santos JM, dos Santos FL, Gikovate CG, Santos-Rebouças CB, Pimentel MM (2011) A MECP2 missense mutation within the MBD domain in a Brazilian male with autistic disorder. Brain Dev 33(10):807–809
Wen Z, Cheng TL, Li GZ, Sun SB, Yu SY, Zhang Y, Du YS, Qiu Z (2017) Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation. Mol Autism 8:43
Shibayama A, Cook EH Jr, Feng J, Glanzmann C, Yan J, Craddock N, Jones IR, Goldman D, Heston LL, Sommer SS (2004) MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet 128B(1):50–53
Coutinho AM, Oliveira G, Katz C, Feng J, Yan J, Yang C, Marques C, Ataíde A, Miguel TS, Borges L, Almeida J, Correia C, Currais A, Bento C, Mota-Vieira L, Temudo T, Santos M, Maciel P, Sommer SS, Vicente AM (2007) MECP2 coding sequence and 3′UTR variation in 172 unrelated autistic patients. Am J Med Genet B Neuropsychiatr Genet 144B(4):475–483
Orrico A, Lam C, Galli L, Dotti MT, Hayek G, Tong SF, Poon PM, Zappella M, Federico A, Sorrentino V (2000) MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 481(3):285–288
Couvert P, Bienvenu T, Aquaviva C, Poirier K, Moraine C, Gendrot C, Verloes A, Andrès C, Le Fevre AC, Souville I, Steffann J, des Portes V, Ropers HH, Yntema HG, Fryns JP, Briault S, Chelly J, Cherif B (2001) MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 10(9):941–946
Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A (2002) A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 70(4):1034–1037
Yntema HG, Oudakker AR, Kleefstra T, Hamel BCJ, van Bokhoven H, Chelly J, Kalscheuer VM, Fryns J-P, Raynaud M, Moizard M-P, Moraine C (2002) In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 107:81–83
Moog U, Van Roozendaal K, Smeets E, Tserpelis D, Devriendt K, Buggenhout GV, Frijns JP, Schrander-Stumpel C (2006) MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients. Brain Dev 28(5):305–310
Meloni I, Bruttini M, Longo I, Mari F, Rizzolio F, D’Adamo P, Denvriendt K, Fryns JP, Toniolo D, Renieri A (2000) A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 67(4):982–985
Cohen D, Lazar G, Couvert P, Desportes V, Lippe D, Mazet P, Héron D (2002) MECP2 mutation in a boy with language disorder and schizophrenia. Am J Psychiatry 159(1):148–149
Adegbola AA, Gonzales ML, Chess A, LaSalle JM, Cox GF (2009) A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype. Hum Genet 124(6):615–623
Suter B, Treadwell-Deering D, Zoghbi HY, Glaze DG, Neul JL (2014) Brief report: MECP2 mutations in people without Rett syndrome. J Autism Dev Disord 44(3):703–711
Cukier HN, Perez AM, Collins AL, Zhou Z, Zoghbi HY, Botas J (2008) Genetic modifiers of MeCP2 function in Drosophila. PLoS Genet 4(9):e1000179
Pietri T, Roman AC, Guyon N, Romano SA, Washbourne P, Moens CB, de Polavieja GG, Sumbre G (2013) The first mecp2-null zebrafish model shows altered motor behaviors. Front Neural Circ 7:118
Leong WY, Lim ZH, Korzh V, Pietri T, Goh EL (2015) Methyl-CpG binding protein 2 (Mecp2) regulates sensory function through Sema5b and Robo2. Front Cell Neurosci 9:481
Chen Y, Yu J, Niu Y, Qin D, Liu H, Li G, Hu Y, Wang J, Lu Y, Kang Y, Jiang Y, Wu K, Li S, Wei J, He J, Wang J, Liu X, Luo Y, Si C, Bai R, Zhang K, Liu J, Huang S, Chen Z, Wang S, Chen X, Bao X, Zhang Q, Li F, Geng R, Liang A, Shen D, Jiang T, Hu X, Ma Y, Ji W, Sun YE (2017) Modeling Rett syndrome using TALEN-edited MECP2 mutant cynomolgus monkeys. Cell 169(5):945–955
Tate P, Skarnes W, Bird A (1996) The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet 12:205–208
Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27(3):327–331
Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27(3):322–326
Pelka GJ, Watson CM, Radziewic T, Hayward M, Lahooti H, Christodoulou J, Tam PP (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 129(Pt 4):887–898
Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143–1147
Luikenhuis S, Giacometti E, Beard CF, Jaenisch R (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci U S A 101(16):6033–6038
Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM (2006) Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry 59(5):468–476
Chin EW, Lim WM, Ma D, Rosales FJ, Goh EL (2018) Choline rescues behavioural deficits in a mouse model of Rett syndrome by modulating neuronal plasticity. Mol Neurol. https://doi.org/10.1007/s12035-018-1345-9
Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, Moretti P, McGill BE, Goulding EH, Sullivan E, Tecott LH, Zoghbi HY (2008) Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59(6):947–958
Motil KJ, Schultz RJ, Abrams S, Ellis KJ, Glaze DG (2006) Fractional calcium absorption is increased in girls with Rett syndrome. J Pediatr Gastroenterol Nutr 42(4):419–426
Perello M, Chuang JC, Scott MM, Lutter M (2010) Translational neuroscience approaches to hyperphagia. J Neurosci 30(35):11549–11554
Lucki I (1998) The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44:151–162
Gordon JA, Hen R (2004) The serotonergic system and anxiety. Neuromolecular Med 5:27–40
Popova NK (2008) From gene to aggressive behavior: the role of brain serotonin. Neurosci Behav Physiol 38:471–475
Samaco RC, Mandel-Brehm C, Chao HT, Ward CS, Fyffe-Maricich SL, Ren J, Hyland K, Thaller C, Maricich SM, Humphreys P, Greer JJ, Percy A, Glaze DG, Zoghbi HY, Neul JL (2009) Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A 106(51):21966–21971
Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35(2):243–254
Bienvenu T, Chelly J (2006) Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet 7(6):415–426
Colvin L, Leonard H, de Klerk N, Davis M, Weaving L, Williamson S, Christodoulou J (2004) Refining the phenotype of common mutations in Rett syndrome. J Med Genet 41(1):25–30
Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, Zoghbi H, Percy A, Glaze DG (2008) Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70(16):1313–1321
Lawson-Yuen A, Liu D, Han L, Jiang ZI, Tsai GE, Basu AC, Picker J, Feng J, Coyle JT (2007) Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice. Brain Res 1180:1–6
Schaevitz LR, Gómez NB, Zhen DP, Berger-Sweeney JE (2013) MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits. Genes Brain Behav 12(7):732–740
Wegener E, Brendel C, Fischer A, Hülsmann S, Gärtner J, Huppke P (2014) Characterization of the MeCP2R168X knockin mouse model for Rett syndrome. PLoS One 9(12):e115444
Pitcher MR, Herrera JA, Buffington SA, Kochukov MY, Merritt JK, Fisher AR, Schanen NC, Costa-Mattioli M, Neul JL (2015) Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene. Hum Mol Genet 24(9):2662–2672
Baker SA, Chen L, Wilkins AD, Yu P, Lichtarge O, Zoghbi HY (2013) An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152(5):984–996
Jentarra GM, Olfers SL, Rice SG, Srivastava N, Homanics GE, Blue M, Naidu S, Narayanan V (2010) Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci 11:19
Schaevitz LR, Moriuchi JM, Nag N, Mellot TJ, Berger-Sweeney J (2010) Cognitive and social functions and growth factors in a mouse model of Rett syndrome. Physiol Behav 100(3):255–263
Carrette LLG, Blum R, Ma W, Kelleher RJ 3rd, Lee JT (2018) Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function. Proc Natl Acad Sci U S A 115(32):8185–8190
Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468(7321):263–269
Moretti P, Bouwknecht JA, Teague R, Paylor R, Zoghbi HY (2005) Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Genet 14(2):205–220
Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B, Armstrong D, Arancio O, Sweatt JD, Zoghbi HY (2006) Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 26(1):319–327
McGill BE, Bundle SF, Yaylaoglu MB, Carson JP, Thaller C, Zoghbi HY (2006) Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 103(48):18267–18272
Goffin D, Allen M, Zhang L, Amorim M, Wang IT, Reyes AR, Mercado-Berton A, Ong C, Cohen S, Hu L, Blendy JA, Carlson GC, Siegel SJ, Greenberg ME, Zhou Z (2011) Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci 15(2):274–283
Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, Guy J, Kastan NR, Robinson ND, de Lima Alves F, Rappsilber J, Greenberg ME, Bird A (2013) Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat Neurosci 16(7):898–902
Ebert DH, Gabel HW, Robinson ND, Kastan NR, Hu LS, Cohen S, Navarro AJ, Lyst MJ, Ekiert R, Bird AP, Greenberg ME (2013) Nature 499(7458):341–345
Motil KJ, Schultz RJ, Browning K, Trautwein L, Glaze DG (1999) Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr 29(1):31–37
Kleefstra T, Yntema HG, Oudakker AR, Romein T, Sistermans E, Nillessen W, van Bokhoven H, de Vries BB, Hamel BC (2002) De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Clin Genet 61(5):359–362
Santos M, Silva-Fernandes A, Oliveira P, Sousa N, Maciel P (2007) Evidence for abnormal early development in a mouse model of Rett syndrome. Genes Brain Behav 6(3):277–286
Stearns NA, Schaevitz LR, Bowling H, Nag N, Berger UV, Berger-Sweeney J (2007) Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome. Neuroscience 146(3):907–921
Karp NA, Mason J, Beaudet AL, Benjamini Y, Bower L, Braun RE, Brown SDM, Chesler EJ, Dickinson ME, Flenniken AM, Fuchs H, Angelis MH, Gao X, Guo S, Greenaway S, Heller R, Herault Y, Justice MJ, Kurbatova N, Lelliott CJ, Lloyd KCK, Mallon AM, Mank JE, Masuya H, McKerlie C, Meehan TF, Mott RF, Murray SA, Parkinson H, Ramirez-Solis R, Santos L, Seavitt JR, Smedley D, Sorg T, Speak AO, Steel KP, Svenson KL, International Mouse Phenotyping Consortium, Wakana S, West D, Wells S, Westerberg H, Yaacoby S, White JK (2017) Prevalence of sexual dimorphism in mammalian phenotypic traits. Nat Commun 8:15475
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Chin, E.W.M., Goh, E.L.K. (2019). MeCP2 Dysfunction in Rett Syndrome and Neuropsychiatric Disorders. In: Kobeissy, F. (eds) Psychiatric Disorders. Methods in Molecular Biology, vol 2011. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9554-7_33
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9554-7_33
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9553-0
Online ISBN: 978-1-4939-9554-7
eBook Packages: Springer Protocols